Quick Links

 Selected Publications

Rodriguez R, Parker P, Nademanee A, Smith D, O’Donnell MR, Stein A, Snyder DS, Fung HC, Krishnan AY, Popplewell, L, Cohen, S, Somlo G, Angelopoulou M, Al-Kadhimi Z, Falk PM, Spielberger R, Kogut N, Sahebi F, Senitzer D, Slovak M, Schriber J, Forman SJ.  Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation:  a prospective study of 22 patients with hematologic malignancies.  Bone Marrow Transplantation 33(11):  1123-1129  June 2004.

Fung H, Stein A, Slovak ML, O’Donnell M, Snyder D, Cohen S, Smith D, Krishnan A, Spielberger R, Bhatia R, Bhatia S, Falk P, Molina A, Nademanee A, Parker P, Rodriguez R, Rosenthal J, Sweetman R, Kogut N, Sahebi F, Popplewell L, Vora N, Somlo G, Margolin K, Chow W, Smith E and Forman SJ.  A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: Impact of cytogenetic characteristics on transplantation outcome.  Biol Blood Marrow Transplant. 2003 Dec 9(12): 766-771.

Stein A, O’Donnell M, Slovak M, Snyder D, Nademanee A, Parker P, Molina A, Somlo G, Kashyap A, Fung HC, Krishnan A, Rodriguez R, Popplewell L, Cohen S, Falk P, Kogut N, Sahebi F, Spielberger R, Wang S, Dagis A, Vora N, Arber D, Niland JC and Forman SJ.  Interleukin–2 following autologous stem cell transplantation for adult patients with acute myeloid leukemia in first complete remission.  J Clin Oncol 21:615-623; 2003.

Fung H, Cohen S, Rodriguez R, Smith D, Krishnan A, Somlo G, Sahebi F, Senitzer D, O’Donnell M, Stein A, Snyder D, Spielberger R, Bhatia R, Falk P, Molina A, Nademanee A, Parker P, Kogut N, Popplewell L, Vora N, Margolin K and Forman SJ.  Reduced intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.  Biol Blood Marrow Transplant 2003: 9(10); 649-656.

Fung H, Stein A, Slovak M, O’Donnell M, Snyder D, Cohen S, Smith D, Krishnan A, Spielberger R, Bhatia R, Bhatia S, Falk P, Molina A, Nademanee A, Parker P, Rodriguez R, Rosenthal J, Sweetman R, Kogut N, Sahebi F, Popplewell L, Vora N, Somlo G, Margolin K, Chow W, Smith E and Forman SJ.  A long term follow up report of allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome.  Biol Blood Marrow Transplant 2003: 9(12); 766-771.

Ishizawa S, Slovak ML, Popplewell L, Bedell V, Wrede JE, Carter NH, Snyder DS and Arber DA.  High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.  Leukemia 2003 Vol 17, 1091-1095.

Fung H, Cohen S, Rodriguez R, Smith D, Krishnan A, Somlo G, Sahebi F, Senitzer D, O’Donnell MR, Stein A, Snyder DS, Spielberger R, Bhatia R, Falk P, Molina A, Nademanee A, Parker, Kogut N, Popplewell L, Vora N, Margolin K and Forman SJ.  Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.  Biol Blood Marrow Transplant. 2003 Oct 9(10): 649-656.

Arber DA, Slovak ML, Popplewell L, Bedell V, Ikle D and Rowley JD for the international workshop on leukemia karyotype and prior therapy.  American Journal of Clinical Pathology 2002, 117:  306 – 313.

Ahuja HG, Popplewell L, Tcheurekdjian L and Slovak ML.  NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia.  Genes, Chromosomes and Cancer 2001, 30:  410 – 415.

Popplewell L and Forman SJ.  Allogeneic hematopoietic stem cell transplantation for acute leukemia, chronic leukemia and myelodysplasia.  Hematology/Oncology Clinics of North America 1999,13:  987 - 1016.

Rao PH, Houldsworth J, Dyomina K, Parsa NZ, Cigudosa JC, Louie DC, Popplewell L, Offit K, Jhanwar SC and Chaganti RS.  Chromosomal and gene amplification in diffuse large B-cell lymphoma.  Blood 1998, 92:  234 - 240.

Flynn M, Popplewell L and Moore C.  Anatomic location and variety of non-malignant neck masses seen in clinical practice.  The American Surgeon 1991; 57:  451 - 453.
 
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.